QPS Bio-Kinetic Names Brendon Bourg Vice President and General Manager
QPS Bio-Kinetic, one of the largest independent Phase 1 Clinical Research Organization (CRO) facilities in the country, today announces the appointment of Brendon Bourg as Vice President and General Manager. Bourg will administer and monitor all aspects of the Phase 1 facility and report to Ben Chein, President and CEO of QPS Holdings, LLC.
Springfield, MO, December 19, 2016 --(PR.com)-- Since joining the organization over 20 years ago, Bourg has provided expertise in logistics, project management, and study coordination. Experience in every aspect of the CRO, he served as the director of budgeting and scheduling prior to accepting the position as the general manager and vice president.
“We are fortunate to have someone with Brendon’s unique history and background,” QPS Chief Operations Officer, Dr. Kumar Ramu said. “As we continue to expand to new markets, his organizational knowledge and experience in the pharmaceutical industry will prove to be an invaluable resource.”
Bourg will provide strategic leadership for QPS’s Springfield operations, overseeing the staff of 95 and continuing to lead biopharmaceutical studies at QPS Bio-Kinetic.
About QPS Bio-Kinetic
QPS Bio-Kinetic, www.417studies.com, is a drug development services company that designs and conducts Phase I clinical studies for branded pharmaceutical, bio-technology, and generic drug companies. The company is known for its clinical quality, having developed an outstanding reputation for study designs, recruiting, and screening study participants, and collecting and reporting clinical data. Connect with QPS Bio-Kinetic at https://www.facebook.com/QPSBioKinetic/.
About QPS
Founded in 1995, Quest Pharmaceutical Services is a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development. QPS provides quality services to pharmaceutical and biotechnology clients worldwide. QPS’ regional laboratories and testing facilities are located at our headquarters in Newark, DE, USA; Springfield, MO, USA; Miami, FL, USA; Groningen, The Netherlands; Graz, Austria; Hyderabad, India and Taipei, Taiwan.
“We are fortunate to have someone with Brendon’s unique history and background,” QPS Chief Operations Officer, Dr. Kumar Ramu said. “As we continue to expand to new markets, his organizational knowledge and experience in the pharmaceutical industry will prove to be an invaluable resource.”
Bourg will provide strategic leadership for QPS’s Springfield operations, overseeing the staff of 95 and continuing to lead biopharmaceutical studies at QPS Bio-Kinetic.
About QPS Bio-Kinetic
QPS Bio-Kinetic, www.417studies.com, is a drug development services company that designs and conducts Phase I clinical studies for branded pharmaceutical, bio-technology, and generic drug companies. The company is known for its clinical quality, having developed an outstanding reputation for study designs, recruiting, and screening study participants, and collecting and reporting clinical data. Connect with QPS Bio-Kinetic at https://www.facebook.com/QPSBioKinetic/.
About QPS
Founded in 1995, Quest Pharmaceutical Services is a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development. QPS provides quality services to pharmaceutical and biotechnology clients worldwide. QPS’ regional laboratories and testing facilities are located at our headquarters in Newark, DE, USA; Springfield, MO, USA; Miami, FL, USA; Groningen, The Netherlands; Graz, Austria; Hyderabad, India and Taipei, Taiwan.
Contact
QPS Bio-Kinetic
Angela Frizell
417 831 2048
www.417studies.com
Angela Frizell
417 831 2048
www.417studies.com
Contact
Categories